Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest High-density lipoprotein Stories

2014-04-02 08:26:30

First and Goal Campaign encourages small, achievable accomplishments in cholesterol management NEW YORK, April 2, 2014 /PRNewswire/ -- Kowa Pharmaceuticals America, Inc. today announced a partnership with Kurt Warner, Super Bowl winner and two-time NFL MVP, and his wife Brenda, to launch First and Goal, a national education initiative to help people prioritize heart health. The campaign encourages the 71 million Americans living with high cholesterol to develop a personalized game plan to get...

2014-03-31 13:27:54

Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death, heart attack or stroke among patients with type 2 diabetes and recent heart attack or unstable angina, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions. Cardiovascular disease remains the dominant cause of death among patients with...

2014-03-31 12:29:54

"RVX-208 decreases Major Adverse Cardiac Events (MACE) in patients with systemic inflammation" TSX Exchange Symbol: RVX CALGARY, March 31, 2014 /PRNewswire/ - Resverlogix Corp. (TSX: RVX) today announced that ASSURE data will be presented at the ACC conference in Washington DC. The poster titled "Effects of an Apolipoprotein A-1 Inducer on Progression of Coronary Atherosclerosis and Cardiovascular Events in Patients with Elevated Inflammatory Markers" will be presented by...

2014-03-31 12:28:19

Findings Presented at the American College of Cardiology Annual Meeting Using the VAP® Lipid Panel Highlight Connection between Lipoproteins and Risk of Coronary Heart Disease WASHINGTON, March 31, 2014 /PRNewswire/ -- Data presented from two meta-analyses using the Atherotech Vertical Auto Profile (VAP(®))( )Lipid Panel showed the impact high-density lipoprotein (HDL) cholesterol and remnant lipoprotein (RLP) cholesterol have on determining a patient's risk for hard coronary heart...

2014-03-31 12:28:14

Data demonstrates that the NMR LipoProfile® test provides clinically reliable information to help reduce cardiovascular events, especially in patients with diabetes and those on statin therapy WASHINGTON, March 31, 2014 /PRNewswire/ -- LipoScience, Inc. (NASDAQ: LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced data showing that...

2014-03-31 12:28:11

- Reductions of up to 64 percent in triglycerides achieved CARLSBAD, Calif., March 31, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced the final results from its Phase 2 study of ISIS-APOCIII(Rx) in patients with high to severely high triglycerides on stable doses of fibrates. In this study, patients treated with ISIS-APOCIII(Rx) achieved average reductions of up to 71 percent in apolipoprotein C-III (apoC-III) and up to 64 percent in triglycerides, and...

Winter's Cold May Lead To Higher Cholesterol Levels: Study
2014-03-28 12:02:26

Brett Smith for redOrbit.com - Your Universe Online Past research has shown that heart attacks and heart-related deaths rise during the winter months and researchers at Johns Hopkins Ciccarone Center for the Prevention of Heart Disease recently found that increased cholesterol levels may be to blame. The new study, which is being presented at the American College of Cardiology's 63rd Annual Scientific Session in Washington, DC this week, is based on cholesterol parameters among a sample...

2014-03-17 16:28:30

"European Patent Office Grants RVX-208 Patent Until 2027" "Resverlogix Receives $2.5 Million for Non-Core ApoA-I Assets" TSX Exchange Symbol: RVX CALGARY, March 17, 2014 /PRNewswire/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) is pleased to announce today that it has received confirmation that its European patent application covering RVX-208 has been granted. European Patent no. 2118074 is titled "Compounds for the prevention and treatment of...

2014-03-04 12:25:48

Dietary Supplement Niacin Helps to Maintain Good Cholesterol within a Healthy Range MAPLE GROVE, Minn., March 4, 2014 /PRNewswire/ -- February has passed and with its close comes the end of American Heart Month. But the end of the month should not be the end of proactively supporting heart health. According to the American Heart Association, an estimated 83.6 million American adults have one or more types of Cardiovascular Disease and 98.9 million Americans age 20 and over have high...

2014-03-03 23:01:45

Kyowa Hakko USA announces that Pantesin is a comprehensive and safe dietary supplement that supports healthy cholesterol levels. New York, NY (PRWEB) March 03, 2014 A recently published study in Vascular Health and Risk Management showed that Pantesin® Pantethine was effective in lowering cardiovascular risk markers in study participants with low to moderate risk factors who were eligible for statin therapy. Specifically when compared to placebo, Pantesin showed significant changes...